
Shontaz 4000mg/500mg Injection
Marketer
Schon Pharmaceuticals Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Shontaz 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, the dosage and frequency are determined by your physician based on illness severity. Strict adherence to prescribed usage is crucial. Common side effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to use, disclose any antibiotic allergies, kidney or liver impairments to your doctor; adjustments to dosage or alternative medications may be necessary. While generally safe under medical guidance, its use during pregnancy and breastfeeding requires physician supervision.
Uses of Shontaz 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Shontaz 4000mg/500mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Shontaz 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Shontaz 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Shontaz 4000mg/500mg Injection works:
Shontaz Injection (4000mg/500mg) combines piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Shontaz 4000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Shontaz, 4000mg/500mg, is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; however, research involving human subjects is currently insufficient.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Shontaz, at a dosage of 4000mg/500mg, presents no known risk during lactation. Research in humans indicates minimal to negligible transfer into breast milk, posing no discernible threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Shontaz 4000mg/500mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Shontaz 4000mg/500mg Injection with close monitoring. Dosage modification of Shontaz 4000mg/500mg Injection might be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Shontaz 4000mg/500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary for this population. However, physician consultation is advised.
What if you forget to take Shontaz 4000mg/500mg Injection :
Should you forget a scheduled injection of Shontaz 4000mg/500mg, seek medical advice immediately.
Facts to Know About Shontaz 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
